Chemotherapy-Induced Anemia Pipeline Insights Report, 2024 Featuring Analysis of Roxadustat (FibroGen), SPP-003 (SBI Pharmaceuticals), and More
May 31, 2024 06:26 ET
|
Research and Markets
Dublin, May 31, 2024 (GLOBE NEWSWIRE) -- The "Chemotherapy-Induced Anemia - Pipeline Insight, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.This report provides...
Intravenous Iron Drugs Global Market Report 2023: Upsurge in Chronic Renal Disease Bolsters Demand
May 17, 2023 06:28 ET
|
Research and Markets
Dublin, May 17, 2023 (GLOBE NEWSWIRE) -- The "Intravenous Iron Drugs Market- Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028: Segmented By Application (Intestinal...
Outlook on the Intravenous Iron Drugs Global Market to 2028 - Featuring Allergan, AbbVie and American Regent Among Others
February 15, 2022 08:04 ET
|
Research and Markets
Dublin, Feb. 15, 2022 (GLOBE NEWSWIRE) -- The "Intravenous Iron Drugs Market Share, Size, Trends, Industry Analysis Report, By Application, By Products, By Region; Segment Forecast, 2021 - 2028"...
Global Intravenous (IV) Iron Drugs Market Report 2021-2027: Market to Reach $2.6 Billion - Ferric Carboxyl Maltose to Account for $1.2 Billion
September 13, 2021 05:48 ET
|
Research and Markets
Dublin, Sept. 13, 2021 (GLOBE NEWSWIRE) -- The "Intravenous (IV) Iron Drugs - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering. Global Intravenous...
Insights on the IV and Oral Iron Drugs Global Market to 2026 - by Route of Administration, Application, Patient Group, Distribution and Geography
February 19, 2021 05:58 ET
|
Research and Markets
Dublin, Feb. 19, 2021 (GLOBE NEWSWIRE) -- The "IV and Oral Iron Drugs Market - Global Outlook and Forecast 2021-2026" report has been added to ResearchAndMarkets.com's offering. In-depth Analysis...